Amount Receivable, Upon Execution of Collaboration Agreement

No definition available.

Name:	aeri_AmountReceivableUponExecutionOfCollaborationAgreement
Namespace Prefix:	aeri_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Collaborative Agreement, Amount Receivable Upon Achievement Of Certain Commercial Milestones

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementAmountReceivableUponAchievementOfCertainCommercialMilestones
Namespace Prefix:	aeri_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Collaborative Agreement, Amount Receivable Upon Achievement Of Certain Development And Regulatory Milestones

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementAmountReceivableUponAchievementOfCertainDevelopmentAndRegulatoryMilestones
Namespace Prefix:	aeri_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Collaborative Agreement, Company's Share Of Collaborative Agreement Costs, Percentage

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementCompanysShareOfCollaborativeAgreementCostsPercentage
Namespace Prefix:	aeri_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Collaborative Agreement, Expiration, Period After First Commercial Sale Of Product

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementExpirationPeriodAfterFirstCommercialSaleOfProduct
Namespace Prefix:	aeri_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Agreement, Reimbursement Of Development Expenses Upon Termination, Percentage

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementReimbursementOfDevelopmentExpensesUponTerminationPercentage
Namespace Prefix:	aeri_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Agreement, Repayment Of Upfront Payment Upon Termination, Percentage

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementRepaymentOfUpfrontPaymentUponTerminationPercentage
Namespace Prefix:	aeri_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Agreement, Royalty Percentage

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementRoyaltyPercentage
Namespace Prefix:	aeri_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Agreement, Termination By Counterparty, Effective After Written Notice Period

+ References

No definition available.

+ Details

Name:	aeri_CollaborativeAgreementTerminationByCounterpartyEffectiveAfterWrittenNoticePeriod
Namespace Prefix:	aeri_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Provisions For Revenue Reserves To Reduce Product Revenues To Product Revenues, Net

+ References

No definition available.

+ Details

Name:	aeri_ProvisionsForRevenueReservesToReduceProductRevenuesToProductRevenuesNet
Namespace Prefix:	aeri_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045

+ Details

Name:	us-gaap_ContractWithCustomerLiabilityNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=aeri_RhopressaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=aeri_DistributorOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=aeri_DistributorTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=aeri_DistributorThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Revenue Recognition (Details) $ in Thousands		12 Months Ended
Revenue Recognition (Details) $ in Thousands	Oct. 28, 2020 USD ($) day	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Disaggregation of Revenue [Line Items]
Provision for revenue reserves to reduce product revenues to product revenues, net		$ 202,200	$ 105,900	$ 19,600
Deferred revenue, non-current		50,858	$ 0
Collaborative Arrangement
Disaggregation of Revenue [Line Items]
Upfront payment receivable	$ 50,000
Contingent payments receivable upon achievement of development and regulatory milestones (up to)	39,000
Contingent payments receivable upon achievement of commercial milestones (up to)	$ 60,000
Royalty percentage (in excess of)	25.00%
Company's share of clinical trial costs, percentage	50.00%
Collaborative agreement expiration, period after first commercial sale of product	12 years
Collaborative agreement, termination by counterparty, effective after written notice period \| day	180
Repayment of upfront payment upon termination, percentage	85.00%
Reimbursement of development expenses upon termination, percentage	50.00%
Deferred revenue, non-current		$ 50,800
Customer Concentration Risk \| Sales Revenue, Net \| Rhopressa \| Distributor One
Disaggregation of Revenue [Line Items]
Concentration risk percentage		37.40%	36.50%
Customer Concentration Risk \| Sales Revenue, Net \| Rhopressa \| Distributor Two
Disaggregation of Revenue [Line Items]
Concentration risk percentage		32.40%	33.30%
Customer Concentration Risk \| Sales Revenue, Net \| Rhopressa \| Distributor Three
Disaggregation of Revenue [Line Items]
Concentration risk percentage		28.80%	28.00%